Target intelligence / Profile preview

microRNA-323a-3p (miR-323a-3p)

Target
miR-323a-3p
Molecular classification
Non-coding RNA, microRNA
01

Overview

MicroRNA-323a-3p (miR-323a-3p) is a small non-coding RNA molecule that serves as a critical post-transcriptional regulator of gene expression. It is encoded within a large microRNA cluster on chromosome 14q32, a region frequently associated with various malignancies and developmental processes [1, 5]. In most oncological contexts, miR-323a-3p acts as a tumor suppressor by targeting and downregulating key oncogenic factors such as STAT3, EGFR, ErbB3, and NEK6, thereby inhibiting cell proliferation and inducing apoptosis [1, 3, 7]. Its downregulation is often correlated with advanced disease stages and poor prognosis in cancers like neuroblastoma and colorectal cancer [1, 2]. Conversely, miR-323a-3p has been identified as a biomarker in inflammatory diseases like rheumatoid arthritis, where its elevated expression in synovial fibroblasts contributes to the inflammatory response [5]. Therapeutic strategies currently under investigation include the use of synthetic miRNA mimics to restore its suppressive function in tumors or antagomirs to modulate its activity in inflammatory conditions [1, 6].

Other names
hsa-miR-323a-3pmiR-323amiR-323-3pmicroRNA 323aMIR323A
02

Mechanism of action

Post-transcriptional gene silencing via RNA interference (RNAi), involving mRNA degradation or translational repression by binding to the 3' untranslated region (UTR) of target mRNAs such as STAT3, EGFR, and NEK6.

03

Biological functions

Gene regulationCell proliferationApoptosisCell cycleImmune responseInflammationCell migrationCell invasion
04

Disease associations

CancerInflammationNeuroblastomaColorectal cancerBreast cancerEsophageal squamous cell carcinomaOsteosarcomaPancreatic ductal adenocarcinomaBladder cancerGlioblastomaRheumatoid arthritis
05

Safety considerations

Off-target effects due to multi-gene targetingDelivery challenges to specific tissuesPotential immunogenicity of synthetic oligonucleotidesTissue-specific dual roles (tumor suppressor vs. oncomir)
06

Interacting drugs

miRNA mimics

2 more in the full profile.

07

Biomarkers

miR-323a-3p expression levels in plasmamiR-323a-3p expression levels in serummiR-323a-3p tissue expression levelsSynovial fibroblast miR-323-3p levels

Beyond the preview

Go deeper on microRNA-323a-3p (miR-323a-3p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-323a-3p (miR-323a-3p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call